Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04647916 |
|---|---|
| Brief Title: | Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases |
| First Submitted : | November 23, 2020 |
| First Submitted that Met QC Criteria : | November 23, 2020 |
| First Posted : | December 1, 2020 |
| Last Update Submitted that Met QC Criteria : | August 11, 2023 |
| Last Update Posted : | August 14, 2023 |